SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
59 hedge funds and large institutions have $152M invested in scPharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
48% more funds holding
Funds holding: 40 → 59 (+19)
11.7% more ownership
Funds ownership: 51.18% → 62.88% (+12%)
56% less call options, than puts
Call options by funds: $302K | Put options by funds: $693K
Holders
59
Holding in Top 10
3
Calls
$302K
Puts
$693K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$12.9M | |
| 3 | +$6.83M | |
| 4 |
Millennium Management
New York
|
+$5.74M |
| 5 |
O
OrbiMed
New York
|
+$5.47M |
Top Sellers
| 1 | -$4.3M | |
| 2 | -$3.13M | |
| 3 | -$2.47M | |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
-$661K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$192K |